NewcelX Ltd. (NCEL) Research

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.

Market snapshot

Symbol
NCEL
Price
$3.31
Day change
+5.08%
Market cap
$1.5M
P/E ratio
-0.61x
52-week range
1.83-30.8
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • IMAC Holdings, Inc. (BACK)
  • BriaCell Therapeutics Corp. (BCTXW)
  • Celularity Inc. (CELU)
  • CERo Therapeutics Holdings, Inc. (CERO)
  • Pasithea Therapeutics Corp. (KTTA)
  • Nuwellis, Inc. (NUWE)
  • Ocean Biomedical, Inc. (OCEA)
  • Prenetics Global Limited (PRE)

Recent insider activity

  • Samuel Olivier — P-Purchase (114545 shares) on 2026-04-27
  • Samuel Olivier — P-Purchase (81818 shares) on 2026-04-27
  • Revel Michel — P-Purchase (54545 shares) on 2026-04-27
  • Revel Michel — P-Purchase (76363 shares) on 2026-04-27
  • Galili Tamar — trade (9117 shares) on 2026-03-18

Open NewcelX Ltd. (NCEL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.